Duke University, Duke Cancer Institute — Durham, North Carolina

Duke University, Duke Cancer Institute is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Duke University, Duke Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma.

Sponsors: pharmaand GmbH.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University, Duke Cancer Institute?

Duke University, Duke Cancer Institute has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University, Duke Cancer Institute conducted?

Duke University, Duke Cancer Institute has 1 clinical trials on record. Their work covers Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma.

Is Duke University, Duke Cancer Institute accredited by Crixeo Health?

Duke University, Duke Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University, Duke Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.